JPH10503652A - インターロイキン−1β転換酵素に関連するヒトタンパク質TxおよびTyをコードしているDNA配列 - Google Patents
インターロイキン−1β転換酵素に関連するヒトタンパク質TxおよびTyをコードしているDNA配列Info
- Publication number
- JPH10503652A JPH10503652A JP8506262A JP50626296A JPH10503652A JP H10503652 A JPH10503652 A JP H10503652A JP 8506262 A JP8506262 A JP 8506262A JP 50626296 A JP50626296 A JP 50626296A JP H10503652 A JPH10503652 A JP H10503652A
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- dna
- protein
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.プロテアーゼ活性を有するヒトポリペプチドをコードし、配列番号1: の配列のヌクレオチド配列を有するDNA配列を含むDNA配列。 2.アポトーシスを誘発できる能力を有するヒトポリペプチドをコードし、配列 番号1: の配列のヌクレオチド配列を有するDNA配列を含むDNA配列。 3.プロテアーゼ活性を有し、かつアポトーシスを誘発できるヒトポリペプチド をコードし、配列番号1: の配列のヌクレオチド配列を有するDNA配列を含むDNA配列。 4.プロテアーゼ活性を有し、かつアポトーシスを誘発できるヒトポリペプチド をコードし、配列番号1の配列のヌクレオチド第42番に始まり、ヌクレオチド 第1,172番で終る配列を有するDNA配列、ならびにそれとハイブリッド形 成し、同じ機能を有するDNA配列。 5.配列番号1の配列のヌクレオチド第42番に始まり、ヌクレオチド第1,1 72番で終る配列を有する請求項4記載のDNA配列。 6.プロテアーゼ活性を有し、アポトーシスを誘発でき、そして配列番号2: の配列のアミノ酸配列を有するヒトポリペプチド、ならびに該配列の対立遺伝子 および類似体。 7.配列番号2の配列のアミノ酸配列を有し、タンパク質Txと称される請求項 6記載のポリペプチド。 8.プロテアーゼ活性を有し、アポトーシスを誘発できるヒトポリペプチドであ って、宿主細胞での、配列番号2の配列のアミノ酸配列をコードしているDNA の発現によって得られるようなヒトポリペプチド。 9.真核宿主細胞での発現によって得られるような請求項8記載のポリペプチド 。 10.そのプロテアーゼ活性が、IL−1βの転換酵素の成熟能力に対応する請 求項6〜9のいずれか一項に記載のポリペプチド。 11.請求項1〜5のいずれか一項に記載のDNA配列を含む発現ベクター。 12.請求項11記載のベクターで形質転換させた宿主細胞。 13.配列番号2の配列のアミノ酸配列をコードしているDNAによって形質転 換させた宿主細胞でのタンパク質Txの発現を含む方法。 14.宿主細胞が真核細胞である請求項13記載の方法。 15.請求項6〜10のいずれか一項に記載のポリペプチドに対して仕向けた抗 体。 16.医薬としての請求項6〜10のいずれか一項に記載のポリペプチド。 17.請求項16記載の医薬を活性成分として含有する製剤組成物。 18.IL−1βの生産を変調するための請求項17記載の製剤組成物。 19.アポトーシスを変調するための請求項17記載の製剤組成物。 20.配列番号1の配列のヌクレオチド第42番に始まり、ヌクレオチド第1, 172番で終るDNA配列とハイブリッド形成し、同じ機能を有する請求項4記 載のDNA配列。 21.プロテアーゼ活性を有し、かつアポトーシスを誘発できるポリペプチドを コードし、配列番号22の配列のヌクレオチド配列を有するDNA配列。 22.ヌクレオチド第104番に始まり、ヌクレオチド第1195番に終わる、 配列番号22の配列の請求項22記載のDNA配列。 23.プロテアーゼ活性を有し、アポトーシスを誘発でき、配列番号23のアミ ノ酸配列を有し、そしてタンパク質Tyと称されるヒトポリペプチド。 24.配列番号23の配列のアミノ酸配列をコードしているDNAの、宿主細胞 での発現によって得られる限りでのヒトポリペプチド。 25.配列番号23の配列のアミノ酸配列をコードしているDNAによって形質 転換された宿主細胞での、タンパク質Tyの発現を含む方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR94/09567 | 1994-08-02 | ||
FR9409567A FR2723378B1 (fr) | 1994-08-02 | 1994-08-02 | Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications |
PCT/FR1995/001035 WO1996004387A1 (fr) | 1994-08-02 | 1995-08-01 | Sequences d'adn codant pour les proteines humaines tx et ty apparentees a l'enzyme de conversion de l'interleukine-1beta |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10503652A true JPH10503652A (ja) | 1998-04-07 |
Family
ID=9465987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8506262A Pending JPH10503652A (ja) | 1994-08-02 | 1995-08-01 | インターロイキン−1β転換酵素に関連するヒトタンパク質TxおよびTyをコードしているDNA配列 |
Country Status (16)
Country | Link |
---|---|
US (2) | US6020477A (ja) |
EP (1) | EP0774004B1 (ja) |
JP (1) | JPH10503652A (ja) |
KR (1) | KR100386708B1 (ja) |
CN (1) | CN100467603C (ja) |
AT (1) | ATE340263T1 (ja) |
AU (1) | AU704426B2 (ja) |
CA (1) | CA2196339C (ja) |
DE (1) | DE69535232T2 (ja) |
DK (1) | DK0774004T3 (ja) |
ES (1) | ES2273337T3 (ja) |
FR (1) | FR2723378B1 (ja) |
HU (2) | HU227707B1 (ja) |
PT (1) | PT774004E (ja) |
RU (1) | RU2214273C2 (ja) |
WO (1) | WO1996004387A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2723378B1 (fr) * | 1994-08-02 | 1996-10-31 | Roussel Uclaf | Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications |
WO1996026280A1 (en) * | 1995-02-21 | 1996-08-29 | Basf Aktiengesellschaft | NOVEL CYSTEINE PROTEASE RELATED TO INTERLEUKIN-1β CONVERTING ENZYME |
US5654146A (en) * | 1995-05-31 | 1997-08-05 | Incyte Pharmaceuticals, Inc. | Human ice homolog |
US6512104B1 (en) | 1996-10-01 | 2003-01-28 | Amgen Inc. | Interleukin-1β converting enzyme like cysteine protease |
US6121018A (en) * | 1997-03-27 | 2000-09-19 | Smithkline Beecham Corporation | Interleukin-1β converting enzyme like apoptosis protease-10 |
AU5340399A (en) * | 1998-08-10 | 2000-03-06 | Incyte Pharmaceuticals, Inc. | Proteases and associated proteins |
US20020077276A1 (en) * | 1999-04-27 | 2002-06-20 | Fredeking Terry M. | Compositions and methods for treating hemorrhagic virus infections and other disorders |
WO2002012561A2 (en) * | 2000-08-03 | 2002-02-14 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the or1g1 gene |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6110701A (en) * | 1994-04-08 | 2000-08-29 | Merck Frosst Canada & Co. | DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
US5552536A (en) * | 1994-04-08 | 1996-09-03 | Merck Frosst Canada, Inc. | DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III) |
WO1996000297A1 (en) * | 1994-06-23 | 1996-01-04 | Human Genome Sciences, Inc. | INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2 |
FR2723378B1 (fr) * | 1994-08-02 | 1996-10-31 | Roussel Uclaf | Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications |
US5856169A (en) * | 1995-02-21 | 1999-01-05 | Thomas Jefferson University | Isoforms of human interleukin-1β converting enzyme and methods of using the same |
US5654146A (en) * | 1995-05-31 | 1997-08-05 | Incyte Pharmaceuticals, Inc. | Human ice homolog |
-
1994
- 1994-08-02 FR FR9409567A patent/FR2723378B1/fr not_active Expired - Fee Related
-
1995
- 1995-08-01 RU RU97103147/14A patent/RU2214273C2/ru not_active IP Right Cessation
- 1995-08-01 EP EP95927005A patent/EP0774004B1/fr not_active Expired - Lifetime
- 1995-08-01 HU HU0400487A patent/HU227707B1/hu not_active IP Right Cessation
- 1995-08-01 HU HU9700302A patent/HU223102B1/hu not_active IP Right Cessation
- 1995-08-01 US US08/776,900 patent/US6020477A/en not_active Expired - Lifetime
- 1995-08-01 WO PCT/FR1995/001035 patent/WO1996004387A1/fr active IP Right Grant
- 1995-08-01 KR KR1019970700700A patent/KR100386708B1/ko not_active IP Right Cessation
- 1995-08-01 AU AU31180/95A patent/AU704426B2/en not_active Ceased
- 1995-08-01 DE DE69535232T patent/DE69535232T2/de not_active Expired - Lifetime
- 1995-08-01 CA CA002196339A patent/CA2196339C/fr not_active Expired - Fee Related
- 1995-08-01 ES ES95927005T patent/ES2273337T3/es not_active Expired - Lifetime
- 1995-08-01 JP JP8506262A patent/JPH10503652A/ja active Pending
- 1995-08-01 DK DK95927005T patent/DK0774004T3/da active
- 1995-08-01 AT AT95927005T patent/ATE340263T1/de active
- 1995-08-01 CN CNB951952013A patent/CN100467603C/zh not_active Expired - Fee Related
- 1995-08-01 PT PT95927005T patent/PT774004E/pt unknown
-
1999
- 1999-03-15 US US09/268,195 patent/US6180386B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69535232T2 (de) | 2007-10-11 |
FR2723378A1 (fr) | 1996-02-09 |
ES2273337T3 (es) | 2007-05-01 |
CA2196339C (fr) | 2009-01-27 |
ATE340263T1 (de) | 2006-10-15 |
HU223102B1 (hu) | 2004-03-29 |
CN100467603C (zh) | 2009-03-11 |
US6020477A (en) | 2000-02-01 |
PT774004E (pt) | 2007-01-31 |
HU227707B1 (en) | 2011-12-28 |
HU0400487D0 (en) | 2004-04-28 |
EP0774004A1 (fr) | 1997-05-21 |
AU704426B2 (en) | 1999-04-22 |
DE69535232D1 (de) | 2006-11-02 |
WO1996004387A1 (fr) | 1996-02-15 |
FR2723378B1 (fr) | 1996-10-31 |
US6180386B1 (en) | 2001-01-30 |
CA2196339A1 (fr) | 1996-02-15 |
CN1158639A (zh) | 1997-09-03 |
EP0774004B1 (fr) | 2006-09-20 |
AU3118095A (en) | 1996-03-04 |
HUT76971A (hu) | 1998-01-28 |
DK0774004T3 (da) | 2007-01-29 |
RU2214273C2 (ru) | 2003-10-20 |
KR100386708B1 (ko) | 2003-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Faucheu et al. | A novel human protease similar to the interleukin‐1 beta converting enzyme induces apoptosis in transfected cells. | |
US6495519B1 (en) | Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 | |
US6730779B2 (en) | Antibody that specifically binds an Mch4 polypeptide | |
US6358725B1 (en) | Mouse aspartic secretase-1 (mASP1) | |
US6361975B1 (en) | Mouse aspartic secretase-2(mASP-2) | |
US5856169A (en) | Isoforms of human interleukin-1β converting enzyme and methods of using the same | |
WO1996000242A1 (en) | Retinoic acid receptor epsilon | |
JPH10503652A (ja) | インターロイキン−1β転換酵素に関連するヒトタンパク質TxおよびTyをコードしているDNA配列 | |
CA2187162C (en) | Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) | |
JPH10201487A (ja) | 哺乳動物のfin−1核酸および蛋白質配列およびその使用 | |
KR20010052887A (ko) | 안지오스타틴-결합 단백질 | |
WO1995027793A1 (en) | DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II) | |
JP2002186492A (ja) | ヒトrce1 | |
US6835555B1 (en) | Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 | |
US20040005658A1 (en) | Novel polypeptide-human an1-like protein 16 and the polynucleotide encoding the same | |
US20040038210A1 (en) | Novel polypeptide-type II fibronectin 10 and a polynucleotide encoding the same | |
WO2001083777A1 (fr) | Nouveau polypeptide, serine hydrolase humaine atp-dependante 9.1, et polynucleotide codant pour ce polypeptide | |
WO2001096576A1 (fr) | Nouveau polypeptide, serine hydrolase humaine atp-dependante 10, et polynucleotide codant ce polypeptide | |
WO2001087974A1 (fr) | Nouveau polypeptide, serine hydrolase humaine atp-dependante 35, et polynucleotide codant pour ce polypeptide | |
EP0769023A1 (en) | Retinoic acid receptor epsilon | |
WO2001075042A2 (fr) | Nouveau polypeptide, serine hydrolase humaine atp-dependante 9, et polynucleotide codant pour ce polypeptide | |
JP2002204697A (ja) | ヒトdnaリガーゼiv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041027 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051108 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060208 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060327 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060508 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070619 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071017 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20071220 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20080710 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100104 |
|
RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20100104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100105 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100129 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100325 |